Diabetes Insulin Drug Therapy Linked to Cancer
Recent research has suggested that certain injectable diabetes medications including Januvia ®, Janumet ®, Byetta ®, Bydureon® and Victoza ® may potentially be linked to an increased risk in thyroid cancer, pancreatic cancer and/or pancreatitis, when compared to other diabetic insulin drug therapy treatments. The Strom Law Firm is now investigating and evaluating cases against Januvia®, Janumet®, Byetta®, Bydureon® and Victoza®, Type 2 diabetes injectable insulin drug therapy drugs that have resulted in personal injury or possibly even death. If you or someone you love took one of these drugs and suffered serious side effects, you could be entitled to compensation. Give us a call today to set up a free consultation. 803.252.4800.
Several lawsuits claim the drug manufacturers “overpromoted and underwarned.” Patients also claim they were not adequately warned about the serious and potentially fatal side effects. You and your loved one could be eligible for compensation including: medical bills, pain and suffering, home health care, future surgical costs, lost wages, and wrongful death.
FDA Investigation and Safety Warning
The Food and Drug Administration (FDA) approved Byetta® in 2005; Januvia® in 2006; Janumet® in 2007; and Victoza® in 2010. These drugs were all approved for the treatment of Type 2 diabetes, and have been prescribed to millions of people in the U.S. Since these medications were originally approved, consumer complaints led the FDA to issue strong warnings regarding the safety and possible dangerous, life-threatening side effects of these drugs. Numerous scientific studies have also linked the drugs to an increased risk of pancreatic diseases, including acute pancreatitis and pancreatic cancer.
The Institute for Safe Medication Practices (ISMP) released a Perspective report on GLP-1 Agents for Diabetes April 18, 2013. The ISMP monitors FDA MedWatch reports focused on five types of widely used drug therapies to treat type 2 diabetes. These include Byetta®, Victoza®, Janumet®, and Januvia ®. During a 12 month study, ISMP found adverse drug effects, including increased risk of thyroid and pancreatic cancers, leading to a request for stronger alerts when prescribing the information and requiring studies on long-term effects of the treatment drugs in association with both thyroid and pancreatic cancers.
In March 2013, the FDA requested additional information from researchers who found a suggested increased risk of pancreatitis and pre-cancerous cellular changes in those treated with a class of drug called incretin mimetics, including drugs like Byetta®, Byrduren®, Victoza®, Januvia® and Janumet®.
Schedule a Free Consultation at the Strom Law Firm Today
Drug manufacturers should be held accountable for the harm they cause. Our team of attorneys is currently investigating claims on behalf of individuals who have been diagnosed with pancreatic cancer, as well as families who have lost a loved one after using these harmful injectable insulin drug therapy. Give us a call today for a free consultation. Don’t wait until its too late. 803.252.4800.